COVID-19 Sinovac vaccine, developed by UC and the Chinese laboratory Sinovac Biotech Ltd

Two doses of Sinovac can stop spread of COVID: National Vaccine Institute

About 95% of those who have received two doses of the Sinovac vaccine have developed an immune response which prevents the spread of SARS-CoV-2, or COVID-19, according to research jointly conducted by the Thai Red Cross Emerging Infectious Diseases Health Science Centre of King Chulalongkorn Memorial Hospital and the US Armed Forces Research Institute of Medical Science (USAMD-AFRIMS).

The National Vaccine Institute said that 186 volunteers have joined the clinical trials, to test their immune response to the SARS-CoV-2 virus. All of them had received their second dose of Sinovac vaccine at least two before the trial.

Full story:

By Thai PBS World


The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply